Bionano Expects 2024 Revenue Of $36M-$40M (Prior $37M-$41M) Vs. $38.08M Consensus; Sees Q3 Revenue Of $7.9-$8.9M Vs. $10.09M Consensus
Portfolio Pulse from Benzinga Newsdesk
Bionano Genomics has revised its 2024 revenue guidance to $36M-$40M, down from the previous $37M-$41M, and below the $38.08M consensus. The company also expects Q3 2024 revenue to be $7.9M-$8.9M, significantly lower than the $10.09M consensus.
August 08, 2024 | 7:16 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bionano Genomics has lowered its 2024 revenue guidance and expects Q3 2024 revenue to be significantly below consensus estimates.
The downward revision in revenue guidance for both the full year and Q3 2024 is likely to negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100